Allied Biotech Corporation
TWO: 1780.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Qing Hui Lin
- Employees
- 40
- Headquarters
- Taipei, Taiwan
- IPO year
- 2012
- Market cap
- NT$3.1B
- Website
- https://www.altratene.com
Loading 1780…
Loading profile data…Frequently asked questions about 1780
What does Allied Biotech Corporation (1780.TWO) do?
Allied Biotech Corporation manufactures and sells carotenoids worldwide. Its products include Beta-Carotene that offers yellow to reddish orange shades to appeal color in various applications; Beta-Apo-8'-Carotenal, which is used as a food colorant, and provides a range of orange to red shades; and Lycopene, which offers a range of red shades as...
Where does 1780.TWO trade?
Allied Biotech Corporation (1780.TWO) trades on the Taipei Exchange.
What sector is 1780.TWO in?
Allied Biotech Corporation (1780.TWO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Allied Biotech Corporation?
Qing Hui Lin is the chief executive officer of Allied Biotech Corporation (1780.TWO).
Where is Allied Biotech Corporation headquartered?
Allied Biotech Corporation is headquartered in Taiwan.
Does 1780.TWO pay a dividend?
Yes — Allied Biotech Corporation (1780.TWO) paid a trailing twelve-month dividend of TWD 1.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 1780.TWO go public?
Allied Biotech Corporation (1780.TWO) completed its initial public offering in 2012.